Brimonidine Tartrate
Tier C — Watch / tradeBrimonidine Tartrate
Targets：ADRA2
Brand：Brimocon, Alphagan
Indications (approved)：Rosacea, Ocular hypertension, Open-angle glaucoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| BRIM-001 | 6298-37-9 | quinoxalin-6-amine |
| BRIM-002 | 59803-96-2 | 5-bromoquinoxalin-6-amine hydrobromide |
| BRIM-003 | 134892-46-9 | 5-bromo-6-isothiocyanatoquinoxaline |
Frequently asked questions
What are the approved indications of Brimonidine Tartrate?
Approved indications include: Rosacea, Ocular hypertension, Open-angle glaucoma.
When does the Brimonidine Tartrate patent expire?
No public expiry year is available for Brimonidine Tartrate yet; this page updates once verified.
How many synthesis routes are recorded for Brimonidine Tartrate?
1 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Brimonidine Tartrate intermediates?
All intermediates in Brimonidine Tartrate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Brimonidine Tartrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04